{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:33:20Z","timestamp":1788878000380,"version":"build-2803163510"},"reference-count":17,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Familial transthyretin amyloidosis (ATTR) is a rare hereditary disorder marked by abnormal protein fibril deposits that impair multiple organ functions. Although over 130 mutations have been identified, the p.Ser43Asn variant, which has been associated with amyloidosis involving thyroxine-binding globulin (TBG), is scarcely reported in the literature, especially within the Chinese population.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>We report a case of a 50-year-old male presenting with recurrent episodes of amaurosis fugax. The patient had a family history of cardiac disease. Auxiliary examinations revealed myocardial hypertrophy, and the electrocardiogram indicated conduction delays and abnormal QRS complexes. Nuclear imaging suggested cardiac amyloidosis, and cardiac MRI indicated non-ischemic cardiomyopathy. Genetic testing identified a c.128G\u2009&amp;gt;\u2009A (p.Ser43Asn) mutation, and pathological examination confirmed ATTR amyloidosis. Both pathological findings and mass spectrometry analysis supported this diagnosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>The p.Ser43Asn variant likely impacts TTR protein dimerization and stability, leading to protein misfolding and amyloid fibril deposition in tissues. Early diagnosis is crucial due to the significant heterogeneity of this condition. Our findings emphasize the importance of increased diagnostic awareness, multidisciplinary collaboration, and regional genetic screening. Comparisons with similar cases reported in the literature highlight the shared clinical presentations and diagnostic challenges.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This case adds valuable insight into the clinical manifestations and diagnostic challenges of ATTR amyloidosis with the p.Ser43Asn mutation, particularly in the Chinese population. Future research should aim to develop effective treatment strategies and explore the genetic and environmental factors influencing the phenotypic variability of this rare disorder.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2025.1625485","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T13:25:17Z","timestamp":1756819517000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Case report and literature review of transthyretin amyloidosis with p.Ser43Asn mutation presenting in China"],"prefix":"10.3389","volume":"12","author":[{"given":"Kebinuer","family":"Abulikemu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7141","DOI":"10.1038\/s41467-021-27481-4","article-title":"Structural basis for transthyretin amyloid formation in vitreous body of the eye","volume":"12","author":"Iakovleva","year":"2021","journal-title":"Nat Commun"},{"key":"B2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1056\/NEJMoa1716793","article-title":"Inotersen treatment for patients with hereditary transthyretin amyloidosis","volume":"379","author":"Benson","year":"2018","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC working group on myocardial and pericardial diseases","volume":"42","author":"Garcia-Pavia","year":"2021","journal-title":"Eur Heart J"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1001\/jama.2013.283815","article-title":"Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial","volume":"310","author":"Berk","year":"2013","journal-title":"JAMA"},{"key":"B6","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jacc.2016.03.596","article-title":"Genotype and phenotype of transthyretin cardiac amyloidosis: THAOS (transthyretin amyloid outcome survey)","volume":"68","author":"Maurer","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.1007\/s00415-022-11056-4","article-title":"A compound score to screen patients with hereditary transthyretin amyloidosis","volume":"269","author":"Tozza","year":"2022","journal-title":"J Neurol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3390\/medsci12040058","article-title":"Experience of hereditary amyloidosis with rare variant in ecuador: case reports","volume":"12","author":"Luzuriaga Carpio","year":"2024","journal-title":"Med Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1080\/00015385.2023.2257521","article-title":"Hereditary transthyretin cardiac amyloidosis proven by endomyocardial biopsy: a single-centre retrospective study and literature review","volume":"79","author":"Yu","year":"2024","journal-title":"Acta Cardiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.euje.2005.09.002","article-title":"Dynamic left ventricular outflow tract obstruction in senile cardiac amyloidosis","volume":"7","author":"Mookadam","year":"2006","journal-title":"Eur J Echocardiogr"},{"key":"B11","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s11739-020-02474-1","article-title":"Poor right ventricular function is associated with impaired exercise capacity and ventilatory efficiency in transthyretin cardiac amyloid patients","volume":"16","author":"Bartolini","year":"2020","journal-title":"Intern Emerg Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1080\/13506129.2016.1176020","article-title":"Abnormal stress echocardiography findings in cardiac amyloidosis","volume":"23","author":"Ong","year":"2016","journal-title":"Amyloid"},{"key":"B13","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12872-017-0519-0","article-title":"Cardiac amyloidosis mimicking severe aortic valve stenosis\u2014a case report demonstrating diagnostic pitfalls and role of dobutamine stress echocardiography","volume":"17","author":"Salinger","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"key":"B14","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3109\/13506129.2011.638682","article-title":"Technetium pyrophosphate myocardial uptake and peripheral neuropathy in a rare variant of familial transthyretin (TTR) amyloidosis (Ser23Asn): a case report and literature review","volume":"19","author":"Casta\u00f1o","year":"2012","journal-title":"Amyloid"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"key":"B16","first-page":"123","article-title":"Cardiac MRI detection of a rare case of familial cardiac amyloidosis (Ser23Asn): case report with literature review","author":"Daoko","year":"2010","journal-title":"Rep Med Imaging"},{"key":"B17","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1097\/CND.0000000000000110","article-title":"Rapidly progressive transthyretin-mediated amyloidosis in a domino liver transplant recipient of a Ser23Asn donor","volume":"17","author":"Dixit","year":"2016","journal-title":"J Clin Neuromuscul Dis"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1625485\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T13:25:17Z","timestamp":1756819517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1625485\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":17,"alternative-id":["10.3389\/fcvm.2025.1625485"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2025.1625485","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"article-number":"1625485"}}